This Bearish Biotech ETF Is up 16% in the Past Month
October 12, 2021 at 12:34 PM EDT
The biotech sector was one of the darlings amid the vaccine rally in 2020, but there’s since been some bearishness, which is benefiting the Direxion Daily S&P Biotech Bear 3X Shares (LABD). LABD climbed 16% the past month, giving bearish biotech traders something to cheer about. Of...
